Key Opinion Leaders and the Corruption of Medical Knowledge: What the Sunshine Act Will and Won't Cast Light On
Key Opinion Leaders and the Corruption of Medical Knowledge: What the Sunshine Act Will and Won't Cast Light On
复制标题
DOI：
10.1111/jlme.12073
复制
发表时间：
2013-09-01
影响因子：
2.1
通讯作者：
Sismondo, Sergio
中科院分区：
文献类型：
--
作者：
Sismondo, Sergio
制药行业在其营销努力中，经常求助于关键意见领袖或KOL来传播科学信息。在作者的实地考察的基础上，本文记录和研究了KOL在制药公司营销工作中的使用。部分由于KOL的使用，少数具有明确和狭隘利益的公司对医学知识的生产、流通和消费产生了过度的影响。与许多其他机构腐败案件一样，这里的问题是，少数行为者积累了塑造信息的权力，其他许多人正是根据这些信息做出决定的。解决这种腐败的努力应该侧重于纠正当前医学知识政治经济中的巨大失衡。一方面将药品研究和开发与药品营销隔离开来，尽管很难实现，但可以解决这个问题和许多其他问题。
The pharmaceutical industry, in its marketing efforts, often turns to key opinion leaders or KOLs to disseminate scientific information. Drawing on the author's fieldwork, this article documents and examines the use of KOLs in pharmaceutical companies' marketing efforts. Partly due to the use of KOLs, a small number of companies with well-defined and narrow interests have inordinate influence over how medical knowledge is produced, circulated, and consumed. The issue here, as in many other cases of institutional corruption, is that a few actors have accumulated the power to shape the information on which many others base their decisions. Efforts to address this corruption should focus on correcting large imbalances in the current political economy of medical knowledge. A sequestration of pharmaceutical research and development on one hand from pharmaceutical marketing on the other, though difficult to achieve, would address this and many other problems.